Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 839

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 839
---
 in the following instances:

(a) filing, prosecuting, defending or enforcing Patents in the Territory as permitted by this Agreement;

(b) enforcing such Party’s rights or performing its obligations under this Agreement and, with respect to Aadi, exercising its
rights under this Agreement;

(c) seeking, obtaining and maintaining Regulatory Approvals in the Territory (including complying with
the requirements of Regulatory Authorities in the Territory with respect to filing for, obtaining and maintaining such Regulatory Approvals) as permitted by this Agreement;

(d) prosecuting or defending litigation as permitted by this Agreement;

(e) complying with applicable court orders, Applicable Laws, or the listing rules of any recognized stock exchange on which the
Receiving Party’s securities are traded (specifically including the recommendations and requests from the U.S. Securities and Exchange Commission (the “SEC”) or otherwise submitting information to tax or other governmental
authorities);

(f) disclosure in Regulatory Filings in the Territory that the Receiving Party has the right to make under this
Agreement;

(g) disclosure to the Receiving Party’s Affiliates, to actual or potential (sub)licensees and to the Receiving
Party’s and its Affiliates’ Representatives who, in each case, have a need to know such information in order for the Receiving Party to fulfill its obligations and exercise its rights under this Agreement, provided, in each case, that any
such Affiliate, actual or potential (sub)licensees, or Representative agrees to be bound by terms of confidentiality and non-use at least as restrictive as those set forth in this ARTICLE IX; and

(h) disclosure to Third Parties in connection with due diligence or similar investigations by such Third Parties, and disclosure to
potential and existing Third Party investors, collaborators, acquirers, lenders and other financing sources, provided, in each case, that any such Third Party agrees to be bound by reasonable obligations of confidentiality and non-use with respect to the applicable Confidential Information.

Each Party shall be responsible for
any breaches of confidentiality by any of its Affiliates, licensees or sublicensees, Representatives, advisors and Third Parties (to whom it discloses Confidential Information pursuant to Sections 9.3(g), 9.3(h) and 9.4).

Notwithstanding the foregoing, in the event the Receiving Party is required to make a disclosure of the Disclosing Party’s Confidential
Information pursuant to Section 9.3(d) or 9.3(e), it will, except where impracticable, give reasonable advance